HIV Mutation Detail Information

> Y181C Search Result


Mutation Information
Mutation Site Y181C
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Literature Information
PubMed PMID 32183488
Published Year 2020
Journal Molecules (Basel, Switzerland)
Title 2-(Arylamino)-6-(trifluoromethyl)nicotinic Acid Derivatives: New HIV-1 RT Dual Inhibitors Active on Viral Replication.
Author Corona A,Onnis V,Del Vecchio C,Esposito F,Cheng YC,Tramontano E
Evidence The allosteric inhibition of the polymerase function of RT was achieved in the 1990s with non-nucleoside inhibitors (NNRTI) that are still in the first-line therapy, although displaying a fairly low genetic barrier to selection of resistant variants, among which K103N, Y181C, and Y188L are the most common.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation